Operator
Hello, everyone. Thank you for joining us, and welcome to the BioStem Technologies Third Quarter 2026 Earnings Call. [Operator Instructions] I will now hand the conference over to Trip Taylor, Investor Relations. Trip, please go ahead.
Philip Taylor
Associate
Good afternoon, everyone, and thank you for joining our conference call to discuss BioStem’s Third Quarter 2026 Financial Results and Corporate Highlights. Leading the call today will be Jason Matuszewski, the company’s Chair and Chief Executive Officer; and Brandon Poe, the company’s Chief Financial Officer. Barry Hassett, the company’s Chief Commercial Officer, will join for the question-and-answer session.
Before we begin, I’d like to remind everyone that our remarks may contain forward-looking statements based on management’s current expectations. These statements are subject to risks and uncertainties that are more fully described in our earnings press release issued today, our quarterly report on Form 10-Q for the quarter ended September 30, 2026, including under Risk Factors and our filings with the U.S. Securities and Exchange Commission. Our SEC filings can be found on our website or the SEC’s website. Investors are cautioned not to place undue reliance on forward-looking statements.
Finally, this call also includes reference to non-GAAP financial measures. A reconciliation to comparable GAAP measures and related information can be found in our earnings press release posted on the Investor Relations section of BioStem’s website. With that, I’d now like to turn the call over to Jason Matuszewski.